MASLD fatty liver disease self-care
Metabolic dysfunction-associated steatotic liver disease (MASLD), formerly called nonalcoholic fatty liver disease (NAFLD), is a common liver disease that affects people who drink little or no alcohol. MASLD develops when fat builds up in the liver because of common conditions such as obesity, type 2 diabetes, high cholesterol and high blood pressure.
Because these metabolic conditions are at the root of the disease, metabolic dysfunction-associated steatotic liver disease (MASLD) is now being used more often than nonalcoholic fatty liver disease (NAFLD).
MASLD is more than just fat in the liver. It can progress to a more serious form of liver disease called metabolic dysfunction-associated steatohepatitis (MASH), which was formerly called nonalcoholic steatohepatitis (NASH). Over time, MASH can lead to complications such as heart disease, kidney conditions, liver scarring, also called fibrosis, or even liver failure and the need for a liver transplant.
Two medicines have been approved by the Food and Drug Administration for this condition and may be prescribed depending on liver disease severity. Lifestyle changes remain the main way to prevent, manage and sometimes reverse MASLD.
Oct. 08, 2025
- Chopra S, et al. Management of metabolic dysfunction-associated steatotic liver disease (nonalcoholic fatty liver disease) in adults. https://www.uptodate.com/contents/search. Accessed July 23, 2025.
- Kravchuk S, et al. Managing metabolic dysfunction-associated steatotic liver disease (MASLD) in the digital era: Overcoming barriers to lifestyle change. Cureus. 2025; doi:10.7759/cureus.84803.
- Younossi ZM, et al. AGA clinical practice update on lifestyle modification using diet and exercise to achieve weight loss in the management of nonalcoholic fatty liver disease: Expert review. Gastroenterology. 2021; doi:10.1053/j.gastro.2020.11.051.
- Singal AK, et al. ACG clinical guideline: Malnutrition and nutritional recommendations in liver disease. American Journal of Gastroenterology. 2025; doi:10.14309/ajg.0000000000003379.
- Metabolic dysfunction-associated steatotic liver disease (MASLD). American Liver Foundation. https://liverfoundation.org/liver-diseases/fatty-liver-disease/nonalcoholic-fatty-liver-disease-nafld. Accessed Aug. 1, 2025.
- What is the Mediterranean diet? American Heart Association. https://www.heart.org/en/healthy-living/healthy-eating/eat-smart/nutrition-basics/mediterranean-diet. Accessed Aug. 7, 2025.
- Eating, diet, & nutrition for NAFLD & NASH. National Institute of Diabetes and Digestive and Kidney Diseases. https://www.niddk.nih.gov/health-information/liver-disease/nafld-nash/eating-diet-nutrition. Accessed Aug. 6, 2025.
- Zhou R, et al. Self-management behaviours in adults with non-alcoholic fatty liver disease: A cross-sectional survey from China. BMJ Open. 2024; doi:10.1136/bmjopen-2023-078333.
- Kaur M, et al. The influence of coffee on reducing metabolic dysfunction-associated steatotic liver disease in patients with type 2 diabetes: A review. Cureus. 2023; doi:10.7759/cureus.50118.
- Sahu P, et al. A comprehensive review on non-alcoholic fatty liver disease. Cureus. 2023; doi:10.7759/cureus.50159.
- Funuyet-Salas J, et al. Influence of psychological biomarkers on therapeutic adherence by patients with non-alcoholic fatty liver disease: A moderated mediation model. Journal of Clinical Medicine. 2021; doi:10.3390/jcm10102208.
- Rinella ME, et al. AASLD practice guidance on the clinical assessment and management of nonalcoholic fatty liver disease. Hepatology. 2023; doi:10.1097/HEP.0000000000000323.
- Zelber-Sagi S, et al. Practical lifestyle management of nonalcoholic fatty liver disease for busy clinicians. Diabetes Spectrum. 2024; doi:10.2337/dsi23-0009.
- Bu LF, et al. Non-alcoholic fatty liver disease and sleep disorders. World Journal of Hepatology. 2024; doi:10.4254/wjh.v16.i3.304.
- Marti-Aguado D, et al. Cigarette smoking and liver diseases. Journal of Hepatology. 2022; doi:10.1016/j.jhep.2022.01.016.
- Shea S, et al. Non-alcoholic fatty liver disease (NAFLD) and potential links to depression, anxiety, and chronic stress. Biomedicines. 2021; doi:10.3390/biomedicines9111697.
- Managing stress. Centers for Disease Control and Prevention. https://www.cdc.gov/mental-health/living-with/index.html. Accessed Aug. 5, 2025.
- Good sleep for good health. NIH Office of Communications and Public Liaison. https://newsinhealth.nih.gov/2021/04/good-sleep-good-health. Accessed Aug. 5, 2025.
- Commins I, et al. Associations between MASLD, ultra-processed food and a Mediterranean dietary pattern in older adults. Nutrients. 2025; doi:10.3390/nu17091415.
- White GE, et al. Food and alcohol disturbance among people who have undergone bariatric surgery. Obesity Science and Practice. 2024; doi:10.1002/osp4.738.
- Rosenson RS, et al. Statins: Actions, side effects, and administration. https://www.uptodate.com/contents/search. Accessed Aug. 7, 2025.
- Abe RAM, et al. The role of vitamins in non-alcoholic fatty liver disease: A systematic review. Cureus. 2021; doi:10.7759/cureus.16855.
- Quitting smoking: 10 ways to resist tobacco cravings. https://www.mayoclinic.org/diseases-conditions/nicotine-dependence/in-depth/nicotine-craving/art-20045454. Accessed Aug. 8, 2025.